SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-09-055345
Filing Date
2009-10-29
Accepted
2009-10-29 16:19:19
Documents
11
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 v162847_10q.htm 10-Q 1089481
2 v162847_ex10-1.htm EX-10.1 2457
3 GRAPHIC ex10-1pg1.jpg GRAPHIC 415781
4 GRAPHIC ex10-1pg2.jpg GRAPHIC 426391
5 GRAPHIC ex10-1pg3.jpg GRAPHIC 196227
6 v162847_ex10-2.htm EX-10.2 579368
7 GRAPHIC logo.jpg GRAPHIC 2639
8 v162847_ex31-1.htm EX-31.1 10984
9 v162847_ex31-2.htm EX-31.2 10981
10 v162847_ex32-1.htm EX-32.1 8365
11 v162847_ex32-2.htm EX-32.2 8356
  Complete submission text file 0001144204-09-055345.txt   3146343
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 091144864
SIC: 2834 Pharmaceutical Preparations